Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.
about
Effect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in miceElevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma.Immune Activation: Contribution to AIDS-Associated Non-Hodgkin LymphomaAssessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma.Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphomaPhase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes.Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening TrialFactors associated with inflammation markers, a cross-sectional analysis.Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma.Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control studyUsing Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored Workshop.Complete Remission of Methotrexate-Related Epstein-Barr-Virus-Associated Hodgkin-Like Lymphoma following Withdrawal of MTX Coupled with Clarithromycin Administration.Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis.A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma.A review of the role of lymphoma markers and occupational and environmental exposures.Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype.Dietary inflammatory index and non-Hodgkin lymphoma risk in an Italian case-control study.Host factors associated with serologic inflammatory markers assessed using multiplex assays.Interferon-γ-producing B cells induce the formation of gastric lymphoid follicles after Helicobacter suis infection.Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma: Univariate and functionally informed multivariate analyses.Human herpesvirus-encoded kinase induces B cell lymphomas in vivo.Association between low-grade inflammation and Breast cancer and B-cell Myeloma and Non-Hodgkin Lymphoma: findings from two prospective cohortsPre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies
P2860
Q28513259-A6DC631A-5FF9-4D9D-9CEE-44A70FD43C29Q33687930-0A064868-5620-4B92-B2BA-1D1D3CB27721Q33887336-691A18DF-9565-4766-91FB-7913E637E3CFQ34474354-681FA27F-1D16-4F79-A9B4-A8969DC727D7Q34626318-0497CA2A-0B7D-4AFF-8714-3A4895729C3DQ34642403-8CEA2934-7097-4477-991C-36887C29F488Q35112864-7F1EBE66-4EC9-4FE7-BBAC-C75DB517E00AQ35255717-FBD7D2B7-C6AF-466D-85F4-6ED18243CBEAQ35633792-E8EF5B67-B917-4134-B5DA-98480B58560BQ35873666-15B3AC87-3EFC-478B-9C31-29516EFC17F5Q36195016-633BFFF8-220D-48E0-B8A4-249329ECCF12Q36354265-A6DB26BD-46F1-43E6-B867-80F278046B09Q36403297-92B4F979-679E-48AC-AE7F-7ED018D51135Q36505005-EEF7F099-BBAD-4E81-A32F-BD5642EA699CQ36680965-0E572257-99B4-44E2-92EC-0CA29D0DA01CQ36981080-9144779A-7679-4B7F-8805-ED948A5366A9Q37083956-AB0FA133-AD32-49C9-A5B8-344E98EB3709Q38029093-67B96ECE-6B37-44BE-9392-2D8FE4F02D39Q39257959-0D1C32EF-88BD-4070-9A49-8BF127846000Q40201698-2B435E80-41E9-452B-AAAE-6D6F27DD5A88Q40704505-2F23E126-56E2-4711-8D7A-218DEAC8A8D5Q45179088-FB03A8EB-0EDC-402F-8803-A15BA1BE54CCQ52718642-66A95120-3D45-4DE1-A2A3-E7A19726BC68Q54111927-3DD070D8-DC42-42E9-B2AD-103C0740E525Q57419693-343FC619-BC5F-40A1-809C-343B844423FEQ58793783-40D8B049-8F24-4A99-9910-10EF59EAED53
P2860
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.
@ast
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.
@en
type
label
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.
@ast
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.
@en
prefLabel
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.
@ast
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.
@en
P2093
P2860
P50
P1476
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study
@en
P2093
Anna E Lokshin
Karen L Koenig
Sherif Ibrahim
P2860
P2888
P304
P356
10.1007/S10552-010-9560-3
P577
2010-04-07T00:00:00Z